Expert consensus statement on the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: 2024 update.
Nash P, Kerschbaumer A, Konzett V, Aletaha D, Dörner T, Fleischmann R, McInnes I, Primdahl J, Sattar N, Tanaka Y, Trauner M, Winthrop K, de Wit M, Askling J, Baraliakos X, Boehncke WH, Emery P, Gossec L, Isaacs JD, Krauth M, Lee EB, Maksymowych W, Pope J, Scholte-Voshaar M, Schreiber K, Schreiber S, Stamm T, Taylor PC, Takeuchi T, Tam LS, Van den Bosch F, Westhovens R, Zeitlinger M, Smolen JS.
Nash P, et al. Among authors: primdahl j.
Ann Rheum Dis. 2025 May;84(5):664-679. doi: 10.1016/j.ard.2025.01.032. Epub 2025 Mar 3.
Ann Rheum Dis. 2025.
PMID: 40037995
Free article.